Last edition
News about "Zydus Cadila receives US FDA approval for fluphena"
Zydus Cadila receives US FDA approval for fluphenazine HCl tablets
Zydus Cadila has received final approval from US FDA to market fluphenazine hydrochloride tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (Prolixin tablets). This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia)
Zydus Cadila Receives US FDA Approval For Fluphena | 31/05/2021 | By Darshana | 172
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members